(Q46916711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

phase II clinical trial

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Daniel Herchenhorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Rodrigo Dienstmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Fabio A Peixoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Franz S de Campos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Valdelice O Santos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Denise M Moreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hedilene Cardoso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Carlos G Ferreira

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

International Brazilian Journal of Urology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

630-8; discussion 638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

Surgical factors influence bladder cancer outcomes: a cooperative group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382007000500004

10.1590/S1677-55382007000500004

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17980060%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference